These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1288510)

  • 21. [High-dose trospium chloride in therapy of detrusor hyperreflexia].
    Madersbacher H; Stöhrer M; Richter R; Giannetti BM; Mürtz G
    Urologe A; 1991 Jul; 30(4):260-3. PubMed ID: 1926674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prokinetic effect of alpha-adrenergic antagonist, and beta-adrenergic antagonist on gall-bladder motility in humans with gall-stone disease.
    Sengupta S; Modak P; McCauley N; O'Donnell LJ
    Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):581-3. PubMed ID: 17556905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial.
    Cardozo L; Chapple CR; Toozs-Hobson P; Grosse-Freese M; Bulitta M; Lehmacher W; Strösser W; Ballering-Brühl B; Schäfer M
    BJU Int; 2000 Apr; 85(6):659-64. PubMed ID: 10759661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of 5-hydroxytryptamine re-uptake impairs human gall-bladder emptying.
    Gorard DA; Healy JC; O'Donnell LJ; Farthing MJ
    Aliment Pharmacol Ther; 1994 Aug; 8(4):461-4. PubMed ID: 7986972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of curcumin and placebo on human gall-bladder function: an ultrasound study.
    Rasyid A; Lelo A
    Aliment Pharmacol Ther; 1999 Feb; 13(2):245-9. PubMed ID: 10102956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effectiveness of combined low- and standard-dose trospium and solifenacin for moderate overactive bladder symptoms in elderly men and women.
    Kosilov KV; Loparev SA; Ivanovskaya MA; Kosilova LV
    Urol Int; 2014; 93(4):470-3. PubMed ID: 25170796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trospium chloride treatment of overactive bladder.
    Biastre K; Burnakis T
    Ann Pharmacother; 2009 Feb; 43(2):283-95. PubMed ID: 19193592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Parasympathicolytic treatment of abnormal neurogenic bladder function: a urodynamic study (author's transl)].
    Wolters A; Sökeland J; Weil W; Kopf H
    Dtsch Med Wochenschr; 1980 Sep; 105(39):1344-7. PubMed ID: 7460781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of various spasmolytic drugs on isolated human and porcine detrusor smooth muscle.
    Uckert S; Stief CG; Odenthal KP; Becker AJ; Truss MC; Jonas U
    Arzneimittelforschung; 1998 Aug; 48(8):836-9. PubMed ID: 9748713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter phase III trial studying trospium chloride in patients with overactive bladder.
    Rudy D; Cline K; Harris R; Goldberg K; Dmochowski R
    Urology; 2006 Feb; 67(2):275-80. PubMed ID: 16461077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.
    Pietzko A; Dimpfel W; Schwantes U; Topfmeier P
    Eur J Clin Pharmacol; 1994; 47(4):337-43. PubMed ID: 7875185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trospium chloride: a quaternary amine with unique pharmacologic properties.
    Pak RW; Petrou SP; Staskin DR
    Curr Urol Rep; 2003 Dec; 4(6):436-40. PubMed ID: 14622495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials.
    Ginsberg DA; Oefelein MG; Ellsworth PI
    Neurourol Urodyn; 2011 Apr; 30(4):563-7. PubMed ID: 21268101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms.
    Zinner NR; Dmochowski RR; Staskin DR; Siami PF; Sand PK; Oefelein MG
    Neurourol Urodyn; 2011 Sep; 30(7):1214-9. PubMed ID: 21462240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experience with application of trospium chloride in patients with neurogenic detrusor overactivity].
    Shvarts PG; Kadykov AS; Shvedkov VV; Timerbaeva SL; Polevaia EV; Mulach AN
    Urologiia; 2009; (5):24-9. PubMed ID: 20213911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pupillometry: a non-invasive pharmacokinetic and pharmacodynamic method to study the action of trospium chloride (Spasmo-lyt) on smooth muscle].
    Albrecht H; Bruhn R; Lorenz D; Lücker PW; Schumacher M
    Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):585-7. PubMed ID: 6664161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sonographic study of the effect of hyoscin-N-butylbromide on cholecystokinin stimulated gallbladder motility].
    Wagner T; Botzler R; Ritter U
    Z Gastroenterol; 1984 Jun; 22(6):305-10. PubMed ID: 6464523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability of trospium chloride after intravesical instillation in patients with neurogenic lower urinary tract dysfunction: A pilot study.
    Walter P; Grosse J; Bihr AM; Kramer G; Schulz HU; Schwantes U; Stöhrer M
    Neurourol Urodyn; 1999; 18(5):447-53. PubMed ID: 10494116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responses of isolated normal human detrusor muscle to various spasmolytic drugs commonly used in the treatment of the overactive bladder.
    Uckert S; Stief CG; Odenthal KP; Truss MC; Lietz B; Jonas U
    Arzneimittelforschung; 2000 May; 50(5):456-60. PubMed ID: 10858873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trospium chloride (Sanctura)--new to the U.S. for overactive bladder.
    Gaines KK
    Urol Nurs; 2005 Feb; 25(1):64-5, 52. PubMed ID: 15779697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.